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An animal model which allows for the implantation 
and development of intracutaneous melanoma is de-
scribed. Intradermal vesicles are created by a negative 
pressure apparatus in DBA/2J mice. 891 melanoma cells 
are injected into the blister cavities. Tumor growth oc-
curs within 7 days and the yield approaches 100%. 
This model is a rapid, efficient, and applicable system 
for the study of melanoma growth dynamics and of the 
effects of systemic and topical anti-tumor agents on 
melanoma proliferation. 
An efficient, appropriate, and applicable animal model of 
intracutaneous melanoma is needed to test numerous hy-
potheses based on in vitro work and to develop new therapeutic 
strategies involving both topical and systemic treatment. Since 
the tumor normally proliferates in the cutis, animal models 
involving tumors located in this area would have increased 
potential import since local factors may play a role in melanoma 
proliferation and responses to therapy. 
Most previous model systems have used subcutaneous tumm· 
implantation. We have developed a murine model of intracu-
taneous melanoma using S91 melanoma cells in a genetically 
susceptible mouse species [1] which closely simulates sponta-
neously occulTing tumors. 
MATERIALS AND METHODS 
Melanoma Cell Cultures 
S91 melanoma cells are placed in 75 cm2 plastic flasks and fed with 
nutrient mixture F-10 (Gibco), 10% horse serum, heat inactivated 2% 
fetal calf serum, 100 uni ts/ml penicillin and 100 ugm/ml streptomycin. 
The cells are fed every other day and passed every 7 days. The cells are 
seeded at 2 X 10'; cells per flask and are divided at confluence in a ratio 
of 1:5. 
Intracutaneous Tumor Implantation 
DBA 2/J male brown mice, 20-25 gm weight are anesthetized with 
Innovar (Pitman-Moore), 0.05 mg intramuscularly. The abdominal skin 
is shaved with a clipper and depilated with a topical depilatory agent 
(Neet). A Dermovac suction blister apparatus (Instrumentarium, Hel-
sinki) is then applied and the pressure is gradually decreased over 2 
min to 75 mm of Hg. The pump is then adjusted to maintian the 
pressw·e for 20 min by which time early vesicles are noted. The pressure 
is increased to 0 mm Hg and the suction cup is removed. 
With the animals in a supine position, 2 million S91 melanoma cells 
in 0.05 ml serum-free media are injected into the blister cavities with a 
30 gauge needle. The mice are held in this position for 5 min afterward 
to aUow the cells to settle to the floor of the vesicle. The animals are 
then returned to their cages and no further restraints are placed on 
their normal activity. The mice are inspected daily for evidence of 
tumor growth. 
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RESULTS 
After 20 min of negative pressure, 3 well-demarcated vesicles 
are present (Fig 1). These correspond to the 3 blister chambers 
of the circular suction cup. 
Little or no inflammation is present clinically around the 
blisters and none occurs over the next week of observation. 
Biopsy of a fresh vesicle confirms that a noninflammatory 
subepidermal bulla is produced. The roof of the blister remains 
intact and little dermal inflammation is noted (Fig 2). 
The tumors may be evident as early as 24 hr after cell 
implantation and are almost all well-developed by 5 days (Fig 
3). They appear as dermal nodules which gradually enlarge. 
The overlying epithelium remains for several weeks until the 
tumors erode through to the surface. 
Histologic examination of a tumor nodule after 7 days reveals 
anaplastic cell masses which extend from the upper dermis 
downward into the deep dermis and subcutaneous layer (Fig 
4) . 
In a series of melanomas implanted in 39 sites on 13 mice, 38 
of the areas grew tumors over a 7-day period for an incidence 
of97%. 
DISCUSSION 
Numerous animal model systems of melanoma have been 
described but all have important Iin1itations. Melanomas may 
be induced chemically. A number of melanoma inducers or 
promoters have been proposed. A system using an anthracene 
derivative as a tumor initiator and a phorbol ester as the 
promoter have been reported [2] but the long latency and 
irregular response rate makes the model impractical. Ethyl 
carbamate (Ul'ethan) has been fed to hamsters [3] and has been 
given by the intraperitoneal route to newborn hamsters [4] but 
only 40-60% of the animals develop melanomas, the time to 
development of the tumors ranges from 29-46 weeks and the 
cutaneous location of the tumors is unpredictable. 
A single neonatal inoculation of a nitrosourea compound, N-
ethyl-N-nitrosourea in gerbils caused cutaneous melanomas to 
develop in 43% of animals but again, one could not predict the 
exact cutaneous location of the tumors and the median time for 
tumor growth to occur was extremely long (909 days) [5]. 
Melanomas may also be surgically implanted. A model of 
melanoma using rabbit cornea as the site of tumor proliferation 
has been described [6-7]. Here tumors grew predictably and 
rapidly but the location did not approximate the sites of natu-
rally-occurring melanoma and so observations of tumor behav-
ior may not be completely valid. The standard method of 
transplanting S91 melanoma cells to establish in vivo tumors 
has been by the subcutaneous route and this is an efficient and 
rapid method of growing these tumors. However this is not the 
location of spontaneous melanoma and so the behavior of these 
tumors may differ from those which proliferate intracutane-
ously. In addition, if one wishes to study topical therapeutic 
modalities, subcutaneous tumor models would not be appropri-
ate. 
We have developed an animal model of intracutaneous mel-
anoma which is reproducible, efficient and which closely ap-
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FIG l. Intracutaneous blisters in mouse skin . Two of the vesicles 
shown here are immediately postinoculation with melanoma ceUs (ar-
r ows). 
proximates naturally-occurring tumors. Cloudman 891 mela-
noma cells are injected into intradermal blister cavities in 
genetically susceptible mice and tumors grow virtually 100% of 
the time within 7 days. In this model system, intradermal 
vesicles are created by a negative pressure suction app:uatus 
which has been used extensively in animals [8] as well as 
humans [9- 11] to produce a relatively noninflammatory bulla. 
In human skin, the cleavage plane is in the junction between 
the basal lamina and the cell membrane of the basal cells [12]. 
In the mouse model described here, the split occurs in the 
upper dermis (Fig 2). 
A major advantage of using negative pressure suction to 
create blisters is that the resultant lesions show only minimal 
signs of cellular damage [9,11). This is critical since overlying 
epidermal necrosis and sloughing would likely decrease the 
number of viable tumor cells and would make subsequent 
studies on the tumors that did grow difficult to control and 
interpret. This is particularly true of experiments using topical 
therapeutic agents. In addition, if one used a modality such as 
liquid nitrogen to produce the blister, the inflammatory envi-
ronment which occurs with this method would greatly interfere 
with melanoma cell survival and proliferation. 
There are several possible applications of this tumor model. 
One could study the growth dynamics of 891 melanoma after 
external pharmacologic, mechanical, or environmental manip-
ulation in a situation which closely approximates the mileau 
seen in human tumor development_ One could study the effects 
of systemic chemotherapeutic anticancer modalities_ One migh t 
also possibly apply the technique of intracutaneous cell implan-
tation to other primary cutaneous neoplasms such as squamous 
cell carcinoma using an appropriate animal modeL 
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FIG 2. B lister cavity after negative pressure suction. The bulla oc-
cuTs in the upper dermis (H & E , X 100). 
FIG 3. Intracutaneous melanoma in ventral mouse skin 5 days post-
tumor ceU inocu lation. 
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FIG 4. Histologic appearance of melanoma 7 days after intracuta-
neous inoculation. Mass of anaplastic pigmented cells from upper 
dermis in to the subcutaneous tissue (H & E, x 100) . 
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